University of Pavia; Rituximab with chemotherapy shows promise for splenic MZL treatment
University of Pavia; Rituximab with chemotherapy shows promise for splenic MZL treatment
About this item
Full title
University of Pavia; Rituximab with chemotherapy shows promise for splenic MZL treatment
Publisher
Atlanta: NewsRx
Journal title
Biotech Week, 2004, p.884
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
2004 SEP 29 - (NewsRx.com & NewsRx.net) -- A chemotherapy regimen with rituximab shows promise for the treatment of splenic marginal zone lymphoma (MZL).
Alternative Titles
Full title
University of Pavia; Rituximab with chemotherapy shows promise for splenic MZL treatment
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_205573087
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_205573087
Other Identifiers
ISSN
1535-2757
E-ISSN
1537-1395
How to access this item
Log in as a Library member
